Omeros Updates Phase 3 Zaltenibart PNH Clinical Trial
March 22, 2025
Omeros Updates Phase 3 Zaltenibart PNH Clinical Trial
March 22, 2025
Accuryn Medical Appoints Todd Dunn as CEO
March 22, 2025
